Understanding Specialty Medications for Your Organization

Specialty medications account for a small percentage of prescriptions but represent a disproportionate share of total drug spend. These therapies are used to treat complex, chronic, and acute conditions—including cancer, autoimmune diseases, and neurological disorders—and require a higher level of clinical oversight and coordination.

Unlike traditional medications, specialty therapies often involve infusion or injectable administration, specialized handling, and ongoing monitoring across multiple care settings. Delivering them effectively depends on aligned pharmacy services, flexible sites of care, and experienced clinical teams.

For healthcare leaders and partners, understanding how specialty medications are managed is essential to balancing outcomes, access, and cost. With the right specialty infusion partner, these therapies can be delivered safely, efficiently, and at scale—supporting both clinical performance and system sustainability.

What Are Specialty Medications?

Specialty medications are a distinct class of therapies used to treat complex, chronic, and rare conditions. They are essential in areas such as oncology, immunology, neurology, and autoimmune disease—but require a very different care and delivery model than traditional prescriptions.

These therapies are typically high-cost, high-touch, and clinically complex. Their safe and effective use depends on coordinated pharmacy services, experienced clinical teams, and flexible sites of care that support continuity and oversight.

Key Characteristics of Specialty Medications

Several defining features set specialty medications apart:

• High cost and clinical impact: Specialty drugs often exceed $600 per month and can reach tens of thousands of dollars annually, accounting for a significant share of total drug spend.
• Biologic complexity: Many are derived from living organisms—such as proteins, antibodies, or plasma—making them highly sensitive to temperature and handling.
• Specialized storage and distribution: Strict cold-chain management is required by the manufacturer through administration.
• Non-oral administration: Many specialty therapies are delivered via infusion or injection and require clinical oversight in home or ambulatory settings.

For therapies such as intravenous immunoglobulin (IVIG) and other time-sensitive biologics, continuity of supply is critical. Coordinated pharmacy and infusion networks support this through pre-positioned inventory, reliable logistics, and flexible site-of-care options across home infusion and ambulatory infusion centers.

How Specialty Medications Differ From Traditional Prescriptions

Traditional prescriptions follow a linear, retail-based workflow. Specialty medications rely on a coordinated, multidisciplinary model that extends well beyond dispensing.

Specialty pharmacy and infusion services bring together pharmacists, nurses, prescribers, payors, and care teams to actively manage therapy initiation, monitoring, and continuation. Coverage pathways are also more complex, often requiring detailed clinical documentation and ongoing reassessment.

For providers, payors, and manufacturers, specialty medications require more than access—they demand an integrated delivery model that balances outcomes, cost, and scalability.

Acelpa Health partners across the healthcare ecosystem to deliver that model with clinical expertise, flexibility, and precision.

Common Health Conditions Requiring Specialty Medications

Specialty medications are central to managing complex, chronic, and rare conditions where standard therapies are insufficient. These diseases often require biologic agents, targeted therapies, or infused treatments supported by coordinated pharmacy and infusion services.

Autoimmune and Inflammatory Diseases

Autoimmune and inflammatory conditions often involve progressive tissue damage without intervention. Specialty therapies target specific pathways to control disease activity and preserve function.

Key examples:

• Rheumatoid Arthritis: TNF inhibitors (Remicade® (infliximab), Avsola® (infliximab-azzq), Inflectra® (infliximab-dyyb)) block inflammatory proteins to slow disease progression.
• Inflammatory Bowel Disease: Entyvio® (vedolizumab) provides gut-selective action, while Humira® addresses systemic inflammation.
• Psoriasis and Neurologic Immunotherapies: Cosentyx® (secukinumab), Skyrizi® (risankizumab), Tysabri® (natalizumab), and Ocrevus® (ocrelizumab) require infusion monitoring, premedication, and post-infusion observation under specialized care teams.

Delivery considerations:

• Many therapies require injections or infusions.
• Cold-chain logistics and site-of-care coordination are critical for treatment continuity.

Oncology and Complex Chronic Conditions

Specialty medications in oncology and chronic disease management deliver targeted treatment and improve long-term outcomes.

Key examples:

• Cancer Immunotherapy: Checkpoint inhibitors (Keytruda® (pembrolizumab), Opdivo® (nivolumab)) enhance the immune system’s ability to fight tumors.
• Chronic Lymphocytic Leukemia (CLL): Targeted oral therapies and monoclonal antibodies are helping people with CLL manage their condition with fewer traditional chemotherapy side effects.
• Multiple Myeloma: Advances in immunomodulatory drugs, proteasome inhibitors, and targeted therapies are improving survival and offering new options, even for patients whose disease has returned after earlier treatment.
• Non-Small Cell Lung Cancer (NSCLC): Precision medicine has transformed care for many patients with NSCLC. Targeted therapies and immunotherapies are selected based on specific genetic markers, helping ensure treatment is personalized to your cancer.

Delivery considerations:

• Infusion timing, monitoring, and coordination across multiple care settings are essential.
• Specialty pharmacy support ensures adherence, coverage navigation, and patient monitoring.

Rare and Orphan Diseases

Rare diseases often require high-cost, highly specialized therapies with precise handling and dosing. Continuity of therapy and expert clinical oversight are critical.

Key examples:

• Hereditary Angioedema (HAE): Medications like Haegarda® (C1 esterase inhibitor, human) help prevent painful and potentially dangerous swelling attacks through regular subcutaneous treatment.
• Severe Combined Immunodeficiency (SCID): Gene therapy and enzyme replacement therapies support immune system function in patients with this rare immune disorder.
• Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): IV or subcutaneous immunoglobulin therapies help reduce nerve inflammation and improve strength.

Delivery considerations:

• Treatments often involve home infusion, ambulatory centers, or specialized administration protocols.
• Clinical oversight ensures safe, uninterrupted therapy and optimal patient outcomes.

What Are Considered Specialty Medications?

Specialty medications are complex, high-impact therapies used to treat chronic, rare, or difficult-to-manage conditions. Their designation affects distribution, handling, patient monitoring, and overall treatment costs. Understanding the defining features of specialty drugs is essential for healthcare organizations, payors, and providers coordinating care.

Criteria for Specialty Drug Classification

Specialty status is determined by multiple factors:

• Cost: Medications exceeding ~$600 per month typically qualify, with many therapies reaching tens of thousands annually.
• Handling complexity: Drugs requiring injection, infusion, or specialized preparation almost always fall into the specialty category.
• Clinical complexity: Treatments for rare diseases, or those needing ongoing monitoring or Risk Evaluation and Mitigation Strategies (REMS), are classified as specialty. REMS programs ensure safety through restricted distribution, patient registries, and mandatory monitoring.

Cost Thresholds and Handling Requirements

The financial impact of specialty medications goes beyond the price tag. Total costs include nursing support, infusion supplies, monitoring labs, and potential hospitalization for adverse events.

Optimizing site-of-care strategies can reduce these costs. Home infusion and ambulatory centers allow safe delivery of IVIG products such as Gamunex-C (immunoglobulin), Gammagard Liquid (immunoglobulin), and Privigen (immunoglobulin), with treatment times typically ranging from 2–5 hours and moderate monitoring.

Temperature control is critical: most biologics require refrigeration (36–46°F) or freezing, and any deviation can compromise efficacy. Investing in specialized storage, packaging, and shipping systems ensures therapy continuity, protects product integrity, and safeguards patient outcomes.

Examples of Specialty Medications

The specialty drug list continues to expand as science advances. Immunology leads with medications treating multiple autoimmune conditions. For example:

• Stelara (ustekinumab): used for both Crohn’s disease and plaque psoriasis
• Xeljanz (tofacitinib): treats rheumatoid arthritis and ulcerative colitis

Neurology specialty medications address conditions from migraines to rare genetic disorders:

• Aimovig (erenumab-aooe): prevents migraines through monthly self-injections
• Spinraza (nusinersen): treats spinal muscular atrophy via intrathecal dosing requiring specialized training
• Tysabri (natalizumab): infusions with TOUCH program requirements for multiple sclerosis
• Ocrevus (ocrelizumab): infusions for multiple sclerosis
• Ultomiris (ravulizumab-cwvz): complement inhibitor therapy with 1.3–2.5 hour infusion and routine monitoring

Prioritizing these medications ensures continuity of care during shipping or scheduling disruptions while maintaining safety and treatment efficacy.

Filling Specialty Medications

Choosing the right pharmacy for specialty prescriptions affects treatment continuity, cost management, and overall outcomes. Unlike standard prescriptions, specialty medications require dedicated infrastructure and expertise.

Specialty Pharmacies vs. Community Pharmacies

Community pharmacies are well-suited for routine medications but typically lack the resources for high-cost, complex therapies. Most cannot maintain temperature-sensitive biologics, manage infusion or injection protocols, or provide ongoing clinical support.

Specialty pharmacies like California Specialty Pharmacy, Hawaii Specialty Pharmacy, ContinuumRx, and Integrated Care Systems operate with purpose-built systems and teams:

• Pharmacists, nurses, patient advocates, and reimbursement specialists trained in complex therapies
• 24/7 clinical support and monitoring for adherence, side effects, and drug interactions
• Sophisticated technology platforms track therapy progress and predict refill needs
• Dedicated inventory and cold-chain logistics for temperature-sensitive medications

Insurance Coverage and Plan Requirements

Many payers require specialty prescriptions to be filled through designated pharmacies or preferred networks, ensuring cost-effective utilization and coverage compliance. Attempting to fill outside these networks can result in claim denials or higher patient costs.

Specialty pharmacies streamline coverage:

• Navigate prior authorizations efficiently
• Help patients explore their insurance and benefits coverage, and costs to cover medications if applicable
• Coordinate transitions between home infusion and ambulatory centers without disrupting therapy

Mail Order and Delivery

Specialty medications are typically shipped directly to patients, prescribers, or infusion centers to ensure safe handling and timely access. Delivery is tightly controlled:

• Temperature-controlled packaging
• Real-time tracking and signature confirmation
• Coordination to align with patient or clinical schedules

By combining operational expertise, clinical oversight, and advanced logistics, specialty pharmacies like Acelpa Health’s network ensure medications are delivered safely, on time, and in a way that supports optimal patient outcomes across care settings.

Specialty Medications Simplified 

Specialty medications have transformed care for complex conditions, from biologics for autoimmune diseases to breakthrough cancer therapies. Their success depends on specialized handling, coordinated care teams, and integrated support services.

Specialty pharmacies act as central coordinators, navigating insurance, ensuring clinical oversight, and maintaining supply chain integrity—especially critical during disruptions to keep therapy on track.

Cost considerations are also key. Manufacturer assistance, insurance optimization, and biosimilar options can improve affordability without compromising outcomes. Partnering with an experienced specialty pharmacy network ensures these complexities are managed efficiently.

For providers, payers, and health systems, Acelpa Health delivers the infrastructure, expertise, and flexibility to optimize outcomes. From home infusion to ambulatory centers and multi-site coordination, Acelpa Health ensures patients receive the right medication, in the right setting, at the right time.

Partner with Acelpa Health to streamline access, protect treatment integrity, and support your patients with confidence.

Frequently Asked Questions (FAQ):

What are examples of specialty medications?

Specialty medications include high-complexity treatments for chronic or rare conditions. Common examples include Humira (adalimumab) for autoimmune diseases, Keytruda (pembrolizumab) for cancer therapies, Trikafta (elexacaftor/tezacaftor/ivacaftor) for cystic fibrosis, and Biktarvy (bictegravir/emtricitabine/tenofovir) for HIV. These medications often require injection or infusion, specialized storage, and close clinical monitoring. They treat conditions such as rheumatoid arthritis, Crohn’s disease, multiple sclerosis, hepatitis C, and rare genetic disorders.

What are specialty medicines?

Specialty medicines are high-cost, high-complexity drugs designed for rare or chronic conditions. They typically exceed $600 per month and often require injection or infusion, specialized handling and storage such as refrigeration, and comprehensive patient support including clinical training, monitoring for adverse effects, and coordination through specialty pharmacies. Most are biologics derived from living organisms and are managed through specialized pharmacy networks rather than traditional retail channels.

What are Tier 4 specialty medications?

Tier 4 medications are specialty brand-name products without generic alternatives. They treat complex, rare, or chronic conditions and represent the highest cost tier in prescription coverage. Preferred Tier 4 drugs may offer better cost-effectiveness than non-preferred options, but all require prior authorization and specialized distribution channels.

What are the top 3 specialty pharmacies?

The largest U.S. specialty pharmacy providers by market share are Express Scripts, CVS Caremark, and OptumRx. Acelpa Health also operates affiliated specialty pharmacies, including California Specialty Pharmacy, Hawaii Specialty Pharmacy, ContinuumRx, Continuum Health, and Integrated Care Systems. These networks provide integrated services, including distribution, clinical support, and patient management for complex therapies requiring specialized handling.